These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 2942780

  • 1. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL, Kato H, Mehra V, Nelson EE, Fan XD, Rea TH, Pattengale PK, Bloom BR.
    Nature; ; 322(6078):459-61. PubMed ID: 2942780
    [Abstract] [Full Text] [Related]

  • 2. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH, Elferink DG, Klatser PR, de Vries RR.
    Nature; ; 322(6078):462-4. PubMed ID: 2426597
    [Abstract] [Full Text] [Related]

  • 3. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I, Van Rood JJ, Mehra NK, Vaidya MC.
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [Abstract] [Full Text] [Related]

  • 4. HLA and leprosy in the pre and postgenomic eras.
    Geluk A, Ottenhoff TH.
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [Abstract] [Full Text] [Related]

  • 5. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 6. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    Modlin RL, Mehra V, Wong L, Fujimiya Y, Chang WC, Horwitz DA, Bloom BR, Rea TH, Pattengale PK.
    J Immunol; 1986 Nov 01; 137(9):2831-4. PubMed ID: 2944966
    [Abstract] [Full Text] [Related]

  • 7. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH, Converse PJ, Gebre N, Wondimu A, Ehrenberg JP, Kiessling R.
    Eur J Immunol; 1989 Apr 01; 19(4):707-13. PubMed ID: 2659369
    [Abstract] [Full Text] [Related]

  • 8. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA.
    J Immunol; 1986 Jun 01; 136(11):4255-63. PubMed ID: 2422278
    [Abstract] [Full Text] [Related]

  • 9. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I, Sathish M, Jayaraman T, Bhutani LK, Sharma AK.
    Clin Exp Immunol; 1984 Dec 01; 58(3):522-30. PubMed ID: 6391762
    [Abstract] [Full Text] [Related]

  • 10. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria.
    Haanen JB, Ottenhoff TH, Lai A Fat RF, Soebono H, Spits H, de Vries RR.
    J Immunol; 1990 Dec 01; 145(11):3898-904. PubMed ID: 1701000
    [Abstract] [Full Text] [Related]

  • 11. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
    Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA.
    J Immunol; 1987 May 01; 138(9):3028-34. PubMed ID: 3106496
    [Abstract] [Full Text] [Related]

  • 12. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
    Janson AA, Klatser PR, van der Zee R, Cornelisse YE, de Vries RR, Thole JE, Ottenhoff TH.
    J Immunol; 1991 Nov 15; 147(10):3530-7. PubMed ID: 1940353
    [Abstract] [Full Text] [Related]

  • 13. The immunobiology of leprosy.
    Kaplan G, Cohn ZA.
    Int Rev Exp Pathol; 1986 Nov 15; 28():45-78. PubMed ID: 3516911
    [Abstract] [Full Text] [Related]

  • 14. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ, Mistry NF, Mahadevan PR, Antia NH.
    J Clin Lab Immunol; 1984 Apr 15; 13(4):189-94. PubMed ID: 6376810
    [Abstract] [Full Text] [Related]

  • 15. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ, Closs O, Belehu A.
    Int J Lepr Other Mycobact Dis; 1982 Dec 15; 50(4):455-67. PubMed ID: 6763003
    [Abstract] [Full Text] [Related]

  • 16. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae.
    Mustafa AS, Qvigstad E.
    Int J Lepr Other Mycobact Dis; 1989 Mar 15; 57(1):1-11. PubMed ID: 2659694
    [Abstract] [Full Text] [Related]

  • 17. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
    Nath I, Singh R.
    Clin Exp Immunol; 1980 Sep 15; 41(3):406-14. PubMed ID: 7002396
    [Abstract] [Full Text] [Related]

  • 18. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun 15; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

  • 19. A peptidoglycan protein complex purified from M. leprae cell walls contains most or all immunodominant M. leprae T-cell antigens.
    Mutis T, van Schooten WC, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1989 Dec 15; 57(4):788-93. PubMed ID: 2681461
    [Abstract] [Full Text] [Related]

  • 20. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
    Mohagheghpour N, Gelber RR, Engleman EG.
    J Immunol; 1987 Jan 15; 138(2):570-4. PubMed ID: 2947952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.